Six new megastigmane glycosides, sedumosides E 1 , E 2 , E 3 , F 1 , F 2 , and G, were isolated from the whole plant of Sedum sarmentosum (Crassulaceae). The structures of new constituents including the absolute configuration were elucidated on the basis of chemical and physicochemical evidence.
In the course of our characterization studies on bioactive constituents from Chinese natural medicines, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] we have reported the isolation and absolute stereostructure elucidation of two megastigmanes, sarmentoic acid and sarmentol A, and six megastigmane glycosides, sedumosides A 1 , A 2 , A 3 , B, C, and D, from the whole plant of Sedum sarmentosum (Crassulaceae) together with eight known megastigmane constituents. As a continuation of the characterization studies on S. sarmantosum, we have isolated six new megastigmane glycosides, sedumosides E 1 (1), E 2 (2), E 3 (3), F 1 (4), F 2 (5) , and G (6) , from this herbal medicine together with 33 known compounds . In this paper, we describe the isolation and absolute stereostructure elucidation of these new megastigmane glycosides (1) (2) (3) (4) (5) (6) .
The hot water extract from the whole plant of S. sarmentosum was treated with methanol to give the methanol-soluble part (0.57% from the fresh plant). The methanol-soluble part was subjected to Diaion HP-20 column chromatography (H 2 O→MeOH) to give the water-and methanol-eluted fractions (0.44 and 0.13%, respectively) as previously reported. 1) The methanol-eluted fraction was subjected to normal-and reversed-phase silica gel column chromatographies, and finally HPLC to give 1 (0.00005%), 2 (0.00018%), 3 (0.00001%), 4 (0.00015%), 5 (0.00018%), 6 (0. (0.00005%). Absolute Stereostructures of Sedumosides E 1 (1), E 2 (2), E 3 (3), F 1 (4), F 2 (5), and G (6) Sedumoside E 1 (1) Enzymatic hydrolysis of 1 with hesperidinase gave (3S,5R,6S,9R)-megastigman-3,9-diol (1a) as the aglycon, whose absolute stereostructure was determined by application of the modified Mosher's method. 44 Fig. 1 . In the heteronuclear multiple bond correlations (HMBC) experiment of 1, long-range correlations were observed between the following proton and carbon pairs (2-H 2 and 1-C; 6-H and 1-C; 3-H and 2, 4-C; 11-H 3 and 1, 2, 6, 12-C; 12-H 3 and 1, 2, 6, 11-C, 13-H 3 and 4, 5, 6-C; 1Ј-H and 3-C; 1Љ-H and 6Ј-C). Consequently, the structure and positions of oligosugar moieties in 1 was clarified and thus the absolute stereostructure of sedumoside E 1 was elucidated to be (3S,5R,6S,9R)-megastigman-3,
Sedumoside E 2 (2) was obtained as an amorphous powder with a negative optical rotation ([a] D 22 Ϫ38.6°in MeOH) and determined as the same molecular formula of 1 from the quasimolecular ion peak at m/z 545 (MϩNa) ϩ in the positive-ion FAB-MS and by high resolution positive-ion FAB-MS measurement. On the other hand, sedumoside E 3 (3) [45] [46] [47] (from 3), which were identified by HPLC analysis using an optical rotation detector. 1, 2, [4] [5] [6] [9] [10] [11] [12] 14) Enzymatic hydrolysis of 2 and 3 with hesperidinase gave (3S,5R,6S,9R)-megastigman-3,9-diol (1a) 44) as the common aglycon. Fig. 1 , the 1 H-1 H COSY experiment on 2 and 3 indicated the presence of partial structures written in bold lines, and in the HMBC experiment, long-range correlations were observed between the following protons and carbons (1Ј-H and 9-C; 1Љ-H and 6Ј-C, respectively). Consequently, the structures and positions of oligosugar moieties in 2 and 3 were clarified and thus the absolute stereostructures of sedumosides E 2 and E 3 were elucidated to be (3S,5R,6S,9R)- Fig. 2 . Consequently, the planar structures of 4 and 5 including the positions of the glycosidic linkages were determined. Next, the relative stereostructures of 4 and 5 were elucidated using nuclear Overhauser enhancement spectroscopy (NOESY), which showed NOE correlations between the following proton pairs (2a-H and 6-H, 12-H 3 ; 2b-H and 3-H; 3-H and 4b-H; 4a-H and 6-H, 13-H 3 ; 6-H and 12-H 3 ; 7-H and 11-H 3 ). To clarify the absolute stereostructures of 4 and 5, we carried out the conversion of 4a into 1a. Thus, hydrogenation of 4a with 10% palladium carbon (Pd-C) under an H 2 atmosphere gave 1a, so that the absolute stereostructures of sarmentol F was elucidated to be trans-(3S,5R,6S,9R)-megastigm-7-en-3,9-diol (4a). On the basis of above-mentioned evidence, the stereostructures of sedumosides F 1 and F 2 were determined to be sarmentol F 9-O-b-Dglucopyranoside (4) and sarmentol
Sedumoside G (6) was obtained as an amorphous powder and exhibited a negative optical rotation ([a] D 19 Ϫ35.7°in MeOH). The IR spectrum of 6 showed absorption bands at 3406, 1716, 1066, and 1047 cm Ϫ1 assignable to hydroxyl, carbonyl, and ether functions. In the positive-ion FAB-MS of 6, a quasimolecular ion peak was observed at m/z 543 (MϩNa) ϩ and high-resolution FAB-MS analysis revealed the molecular formula of 6 to be C 25 H 44 O 11 . The acid hydrolysis of 6 with 1.0 M HCl liberated L-rhamnose and D-glucose, which were identified by HPLC analysis using an optical rotation detector.
1,2,4-6,9-12,14) Enzymatic hydrolysis of 6 with hesperidinase gave a new megastigmane, sarmentol G (6a), as the aglycon. The proton and carbon signals in the 1 H-(CDCl 3 ) and 13 C-NMR (Table 1) Fig. 3 . Consequently, the connectivity of oligosugar part in 6 was clarified to be the 3-position of 6a. The relative 438 Vol. 55, No. 3 stereostructure of 6 was characterized by NOESY experiment, which showed NOE correlations between the following proton pairs (2a-H and 12-H 3 ; 2b-H and 3-H; 3-H and 4b-H; 4a-H and 6-H, 13-H 3 ; 6-H and 12-H 3 ; 7-H 2 and 11-H 3 ). Finally, compound 6 was derived by selective oxidation of the aglycon part in 1 with chromium trioxide (CrO 3 )-pyridine as shown in Fig. 3 . Consequently, the absolute stereostructures of sarmentol G and sedumoside G were clarified to be (3S,5R,6S)-9-oxo-megastigman-3-ol (6a) and its 3-O-a-Lrhamnopyranosyl(1→6)-b-D-glucopyranoside (6) .
Experimental
The following instruments were used to obtain physical data: specific rotations, Horiba SEPA-300 digital polarimeter (lϭ5 cm); CD spectra, JASCO J-720WI spectrometer; UV spectra, Shimadzu UV-1600 spectrometer; IR spectra, Shimadzu FTIR-8100 spectrometer; EI-MS, CI-MS and high-resolution MS, JEOL JMS-GCMATE mass spectrometer; FAB-MS and high-resolution MS, JEOL JMS-SX 102A mass spectrometer; 3S,5R,6S,9R )-megastigman-3,9-diol (1a, 14.8 mg, 0.00003%), which was described previously. Enzymatic Hydrolysis of 1-3, 5, and 6 with Hesperidinase A solution of 1 (4.7 mg) in H 2 O (1.0 ml) was treated with hesperidinase (11.6 mg, from Aspergillus nigar, Sigma) and the solution was stirred at 37°C for 12 h. After EtOH was added to the reaction mixture, the solvent was removed under reduced pressure and the residue was purified by HPLC [MeOH-H 2 O (55 : 45, v/v)] to furnish (3S,5R,6S,9R)-megastigman-3,9-diol (1a, 44) 1.3 mg, 64%). Through the similar procedure, a solution of 2 (17.3 mg), 3 (3.5 mg), 5 (21.0 mg), and 6 (3.2 mg) in H 2 O (1.0 ml) was treated with hesperidinase (49.0, 45.0, 61.6, and 14.5 mg, respectively) and the solution was stirred at 37°C for 12 h gave 1a (5.0 mg, 70% from 2, 0.6 mg, 42% from 3), sarmentol F (4a, 5.2 mg, 61% from 5), and sarmentol G (6a, 0.9 mg, 67% from 6), respectively. , 4a-H), 1.21 (1H, dd, Jϭ12.0, 12.0 Hz, 2a-H Enzymatic Hydrolysis of 4 with b b-Glucosidase A solution of 4 (6.0 mg) in H 2 O (1.0 ml) was treated with b-glucosidase (5.1 mg, from Almond, Oriental yeast Co., Ltd., Tokyo, Japan) and the solution was stirred at 37°C for 24 h. After EtOH was added to the reaction mixture, the solvent was removed under reduced pressure and the residue was purified by HPLC [MeOH-H 2 O (55 : 45, v/v)] to furnish 4a (3.3 mg, 95%).
Hydrogenation of 4a A solution of 4a (1.0 mg) in MeOH (1.0 ml) was treated with 10% palladium carbon (Pd-C, 2.1 mg) and the whole mixture was stirred at room temperature under an H 2 atmosphere for 1 h. The catalyst was filtered off, and the solvent from the filtrate was evaporated under reduced pressure to give a residue, which was purified by normal-phase silica gel column chromatography [100 mg, CHCl 3 -MeOH-H 2 O (10 : 3 : 1, v/v/v, lower layer)] to give 1a 44) (0.6 mg, 60%). CrO 3 -Pyridine Oxidation of 1 A solution of 1 (3.3 mg) in pyridine (0.5 ml) was treated with chromium trioxide (CrO 3 , 1.0 mg)-pyridine (0.5 ml) mixture, and whole mixture was stirred at room temperature for 30 min. The reaction mixture was poured into ice-water. Removal of the solvent under reduced pressure to give a residue, which was purified by HPLC [MeOH-H 2 O (45 : 55, v/v)] to give 6 (1.1 mg, 33%).
